Aug. 30 at 4:00 PM
$SKY $FBIO $ALT.
$VKTX
3 companies I expect to move biggly in the next quarter.
$FBIO trading at current cash value. Revenue of
$15M per quarter and rising. Catalyst due upon FDA approval with pdufa sept 30th will receive
$100M payment.
$SKYE: microcap that has a huge P2 exploring combo therapy for weight loss. Release data has been super promising.
$ALT: Best in class data for MASH, 48 week data will likely continue to show dramatic mash resolution with the added benefit of 10-15% weight loss. If 15-20% weight loss, then this rides to
$20 after data release. FDA reviewing and accepting surrogates could also be a huge catalyst.
$VKTX recent dip has been a gift, hopefully folks took advantage to load up.
Remember, the stock market is a medium to transfer wealth from the impatient to the patient.
Do your own DD. NFA. LFG!
